Stephanie Berg

4.4k total citations
53 papers, 847 citations indexed

About

Stephanie Berg is a scholar working on Surgery, Oncology and Molecular Biology. According to data from OpenAlex, Stephanie Berg has authored 53 papers receiving a total of 847 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Surgery, 15 papers in Oncology and 14 papers in Molecular Biology. Recurrent topics in Stephanie Berg's work include Bladder and Urothelial Cancer Treatments (12 papers), Renal cell carcinoma treatment (9 papers) and Cancer Genomics and Diagnostics (6 papers). Stephanie Berg is often cited by papers focused on Bladder and Urothelial Cancer Treatments (12 papers), Renal cell carcinoma treatment (9 papers) and Cancer Genomics and Diagnostics (6 papers). Stephanie Berg collaborates with scholars based in United States, Germany and China. Stephanie Berg's co-authors include Peg Nopoulos, Stephen D. Roper, Joung W. Kim, Nirupa Chaudhari, Lynn C. Richman, John W. Canady, Nancy C. Andreasen, Seth M. Tomchik, Craig D. Roberts and Yutaka Maruyama and has published in prestigious journals such as Journal of Clinical Oncology, Journal of Neuroscience and SHILAP Revista de lepidopterología.

In The Last Decade

Stephanie Berg

47 papers receiving 826 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stephanie Berg United States 14 290 238 234 156 131 53 847
Denis Lafreniere United States 16 28 0.1× 56 0.2× 307 1.3× 79 0.5× 205 1.6× 31 1.1k
Isabelle Rouillon France 19 108 0.4× 20 0.1× 434 1.9× 15 0.1× 187 1.4× 49 877
Paul Kruszka United States 20 397 1.4× 16 0.1× 197 0.8× 23 0.1× 120 0.9× 66 1.1k
R. Marianowski France 21 43 0.1× 36 0.2× 86 0.4× 23 0.1× 405 3.1× 93 1.0k
Kristina Prelog Australia 15 30 0.1× 54 0.2× 102 0.4× 11 0.1× 58 0.4× 28 1.0k
Ross I. S. Zbar United States 17 125 0.4× 32 0.1× 200 0.9× 35 0.2× 364 2.8× 39 890
Kadir Serkan Orhan Türkiye 14 43 0.1× 27 0.1× 153 0.7× 39 0.3× 295 2.3× 70 649
Douglas C. Bigelow United States 21 16 0.1× 43 0.2× 292 1.2× 53 0.3× 251 1.9× 79 1.2k
Rosaria Turchetta Italy 20 28 0.1× 15 0.1× 430 1.8× 17 0.1× 83 0.6× 56 1.2k
Nobutsune Ishikawa Japan 15 148 0.5× 21 0.1× 20 0.1× 24 0.2× 29 0.2× 52 638

Countries citing papers authored by Stephanie Berg

Since Specialization
Citations

This map shows the geographic impact of Stephanie Berg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephanie Berg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephanie Berg more than expected).

Fields of papers citing papers by Stephanie Berg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephanie Berg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephanie Berg. The network helps show where Stephanie Berg may publish in the future.

Co-authorship network of co-authors of Stephanie Berg

This figure shows the co-authorship network connecting the top 25 collaborators of Stephanie Berg. A scholar is included among the top collaborators of Stephanie Berg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephanie Berg. Stephanie Berg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Simon, Nicholas I., Stephanie Berg, Alan Tan, et al.. (2025). Preferred treatment regimens for rare genitourinary (GU) malignancies.. Journal of Clinical Oncology. 43(5_suppl). 780–780.
2.
3.
McGregor, Bradley A., Lucia Kwak, Guru Sonpavde, et al.. (2024). Sacituzumab govitecan (SG) plus enfortumab vedotin (EV) for metastatic urothelial carcinoma (mUC) treatment-experienced (DAD) and with pembrolizumab (P) in treatment naïve UC (DAD-IO).. Journal of Clinical Oncology. 42(16_suppl). TPS4618–TPS4618. 2 indexed citations
4.
Berg, Stephanie & Bradley A. McGregor. (2024). One Size Fits Some: Approaching Rare Malignancies of the Urinary Tract. Current Treatment Options in Oncology. 25(2). 206–219. 1 indexed citations
5.
Apolo, Andrea B., Karla V. Ballman, Guru Sonpavde, et al.. (2024). AMBASSADOR Alliance A031501: Phase III randomized adjuvant study of pembrolizumab in muscle-invasive and locally advanced urothelial carcinoma (MIUC) vs observation.. Journal of Clinical Oncology. 42(4_suppl). LBA531–LBA531. 20 indexed citations
6.
McGregor, Bradley A., Guru Sonpavde, Lucia Kwak, et al.. (2023). The Double Antibody Drug Conjugate (DAD) phase I trial: sacituzumab govitecan plus enfortumab vedotin for metastatic urothelial carcinoma. Annals of Oncology. 35(1). 91–97. 51 indexed citations
7.
Berg, Stephanie, Lei Zhang, Shanhui Liu, et al.. (2023). Active STAT3 Prevents Selinexor-Induced Caspase-Independent Apoptosis in Multiple Myeloma. Blood. 142(Supplement 1). 6611–6611. 1 indexed citations
8.
Shaw, Reid, Timothy E. O’Connor, Gregory W. Roloff, et al.. (2023). Multicenter analysis of immunosuppressive medications on the risk of malignancy following adult solid organ transplantation. Frontiers in Oncology. 13. 1146002–1146002. 3 indexed citations
9.
Xu, Wenxin, et al.. (2023). First-Line Treatment for Intermediate and Poor Risk Advanced or Metastatic Clear Cell Renal Cell Carcinoma. Hematology/Oncology Clinics of North America. 37(5). 951–964. 1 indexed citations
10.
Zhang, Lei, Stephanie Berg, Shanhui Liu, et al.. (2022). Molecular mechanisms by which splice modulator GEX1A inhibits leukaemia development and progression. British Journal of Cancer. 127(2). 223–236. 6 indexed citations
11.
Berg, Stephanie, et al.. (2022). Increasing genomic discovery in newly diagnosed multiple myeloma: defining disease biology and its correlation to risk. Annals of Hematology. 101(7). 1407–1420. 1 indexed citations
12.
Patel, Hiten D., Sunil Patel, Parth M. Patel, et al.. (2021). Four versus 3 Cycles of Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer: Implications for Pathological Response and Survival. The Journal of Urology. 207(1). 77–85. 15 indexed citations
13.
Berg, Stephanie, et al.. (2020). Auditory cortex reflects goal-directed movement but is not necessary for behavioral adaptation in sound-cued reward tracking. Journal of Neurophysiology. 124(4). 1056–1071. 8 indexed citations
14.
Berg, Stephanie, et al.. (2020). Et Tu, B12? Cobalamin Deficiency Masquerading As Pseudo-Thrombotic Microangiopathy. Cureus. 12(7). e9097–e9097. 9 indexed citations
15.
Berg, Stephanie & Sucha Nand. (2017). Neurological Complications of the Leukemias Across the Ages. Current Neurology and Neuroscience Reports. 17(2). 13–13. 10 indexed citations
16.
Venepalli, Neeta K., Stephanie Berg, Mayur Parepally, et al.. (2017). Features of hepatocellular carcinoma in Hispanics differ from African Americans and non-Hispanic Whites. World Journal of Hepatology. 9(7). 391–391. 19 indexed citations
17.
Haxel, Boris, et al.. (2015). Olfaction in chemotherapy for head and neck malignancies. Auris Nasus Larynx. 43(1). 74–78. 9 indexed citations
18.
Kim, Joung W., Craig D. Roberts, Stephanie Berg, et al.. (2008). Imaging Cyclic AMP Changes in Pancreatic Islets of Transgenic Reporter Mice. PLoS ONE. 3(5). e2127–e2127. 27 indexed citations
19.
Nopoulos, Peg, et al.. (2002). Structural brain abnormalities in adult males with clefts of the lip and/or palate. Genetics in Medicine. 4(1). 1–9. 100 indexed citations
20.
Nopoulos, Peg, et al.. (2001). Increased Incidence of a Midline Brain Anomaly in Patients With Nonsyndromic Clefts of the Lip and/or Palate. Journal of Neuroimaging. 11(4). 418–424. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Denis Lafreniere Breakdown of academic impact, for papers by Isabelle Rouillon Breakdown of academic impact, for papers by Paul Kruszka Breakdown of academic impact, for papers by R. Marianowski Breakdown of academic impact, for papers by Kristina Prelog Breakdown of academic impact, for papers by Ross I. S. Zbar Breakdown of academic impact, for papers by Kadir Serkan Orhan Breakdown of academic impact, for papers by Douglas C. Bigelow Breakdown of academic impact, for papers by Rosaria Turchetta Breakdown of academic impact, for papers by Nobutsune Ishikawa
Rankless by CCL
2026